New study shows evidence of stem cells’ pivotal role in cancerDecember 22nd, 2010 - 5:17 pm ICT by ANI
Washington, Dec 22 (ANI): A Stanford University study has suggested that leukemia patients whose cancers express higher levels of genes associated with cancer stem cells have a significantly poorer prognosis than patients with lower levels of the genes.
The finding is among the first to show that the cancer stem cell hypothesis - which posits that some cancers spring from and are replenished by a small, hardy population of self-renewing cells - can be used to predict outcomes in a large group of patients and one day to tailor treatments in the clinic.
“If we’re not able to design therapies to target this self-renewing population of chemotherapy-resistant cells, the patients will continue to have a tendency to relapse,” said Ash Alizadeh, co-senior author of the study.
In the study, researchers were interested in learning whether leukemia stem cells play a similarly important role in acute myeloid leukemia, which is one of the most aggressive blood cancers in adults.
The team used two cell surface markers formerly shown to identify leukemia stem cells to isolate these cells from tumor samples from seven patients. They then compared the overall gene expression patterns of the stem cells to other cells in the tumors and identified a total of 52 genes whose expression varies between the tumor stem cells and non-stem cells.
Interestingly, the gene expression pattern is similar to that found on normal blood stem cells, which give rise to blood cells and the immune system. This similarity implies that the cancer stem cells not only can self-renew, but also that they, like normal stem cells, don’t divide unless they’re needed. Infrequent division may be one way the cancer stem cells escape many conventional treatments that target rapidly dividing cells.
“It’s as if these cells are lurking in the background, waiting to pounce after chemotherapy has wiped out most of the other cells,” said Alizadeh.
When the researchers compared the levels of expression of these new leukemia stem-cell-associated genes among tumor samples from four groups with a total of more than 1,000 people with acute myeloid leukemia, they found a strong correlation between high levels of expression and a poor outcome for the patients.
The findings were published in the Journal of the American Medical Association. (ANI)
- Small molecule may deactivate enemy of cancer-fighting p53 - Dec 08, 2010
- Gene mutation behind onset of acute myeloid leukaemia identified - Mar 28, 2011
- Mouse genome offers human cancer clue - Mar 24, 2011
- Mechanism that turns healthy cells into prostate cancer cells discovered - Dec 03, 2010
- Bioengineered protein may help fight leukemia - Feb 19, 2011
- Long-sought-after anti-cancer agent synthesized - Feb 01, 2011
- New drug could help older leukemia patients - Jan 13, 2010
- New therapy shows promise in treating advanced leukemia - Nov 06, 2009
- Gene that triggers human cancer identified - Nov 10, 2010
- Mechanism that may trigger degenerative disease discovered - Jun 26, 2010
- Personalized cancer medicine now a step closer to reality - Apr 16, 2011
- Overabundance of protein promotes growth of breast cancer stem cells - Feb 16, 2011
- Intestinal stem cells offer clues to colon cancer origin and relapse - Mar 18, 2011
- Software that predicts stem cell fate created - Feb 17, 2010
- New discovery paves way for treatment of incurable blood cancer - Jul 17, 2010
Tags: acute myeloid leukemia, alizadeh, blood cancers, blood cells, cell surface markers, chemotherapy, conventional treatments, expression pattern, gene expression patterns, large group, leukemia, leukemia patients, normal blood, pivotal role, prognosis, resistant cells, stanford university study, stem cells, study researchers, tumor samples